Investor Update

Reminder: Invitation to Roche’s Virtual Event "Digitalization along the value chain"

We are pleased to invite investors and analysts to participate in a live webinar on Wednesday,
17 November 2021,
highlighting Roche’s development in digital technology, data and advanced analytics.

16:00 - 17:30 CET / 15:00 - 16:30 GMT
10:00 - 11:30 am EST / 07:00 - 08:30 am PST

The webinar will be hosted by Alan Hippe, Chief Financial and IT Officer, and other senior leaders in the space followed by a Q&A session.

The event will outline the overall strategy and highlight >20 use cases (including launched products) from the pharmaceuticals & diagnostics divisions. Use cases presented will cover the entire traditional value chain (early R&D, clinical development, regulatory & reimbursement, manufacturing, commercialization, diagnosis) as well as novel treatment/decision support solutions for physicians and patients.

Presenters include:

  • Alan Hippe, Chief Financial and IT Officer Roche
  • Mark McCarthy, Executive Director, Human Genetics, gRED
  • Christian Gossens, Digital Biomarkers, Global Area Head, pRED
  • Jacqueline Law, Vice president, Head of Corporate Strategy, Flatiron Health
  • Steve Guise, Global Head, Pharma Informatics
  • Moritz Hartmann, Global Head of Roche Information Solutions, Roche Diagnostics

The slides will be available for download at 15:00 CET on the day of the event. > click here

We would like to invite all interested parties to participate in the webinar and to pre-register here.*

Should you be unable to register for the webinar due to your company IT policy, please send an email to

A replay of the webcast will be available via >


*privacy notice

Best regards,

Karl Mahler
Head of Investor Relations

Bruno Eschli
Investor Relations Officer

Gerard Tobin
Investor Relations Officer
Roche Investor Relations 
Dr. Karl Mahler
Phone: +41 61 68-78503

Jon Kaspar Bayard
Phone: +41 61 68-83894
Dr. Sabine Borngräber
Phone: +41 61 68-88027

Dr. Bruno Eschli
Phone: +41 61 68-75284
Dr. Birgit Masjost
Phone: +41 61 68-84814
Dr. Gerard Tobin
Phone: +41 61 68-72942
Investor Relations North America 
Loren Kalm
Phone: +1 650 225 3217